China approves Innovent Biologics’ closely watched weight loss drug Friday, unleashing a potent homegrown competitor against foreign giants Novo Nordisk and Eli Lilly https://t.co/EUmGJx4fHn ...

What's happening with Iran's stock market is hard to learn when you can't even check prices from outside the country https://t.co/wT80rH9bAI ...

A Hong Kong family dynasty in turmoil, with no known succession plan and billions in debt as China’s property crisis continues. How will one of Asia’s richest families navigate these uncertain waters? https://t.co/ITtjOaYwel https://t.co/ojBZKpkiFD ...

RTL Group agrees to buy Comcast’s Sky Deutschland for an upfront price of €150 million https://t.co/1FyiRJJk22 ...

Germany’s Jänschwalde coal plant was on track to be converted to natural gas — until the local heritage office declared it a national monument. https://t.co/GQiau8g26x ...

Babbel’s new CEO says he’s focused on expanding the company’s language-learning product to include emerging AI tools, and he doesn’t intend to revive its IPO https://t.co/KxaqUUuf5k ...

China has removed a top general from the nation’s apex military body led by President Xi Jinping, as the defense establishment is facing a wave of purges https://t.co/pwMQmRhr9f ...

“He hoped that the truth would never come to light.” The ex-Barclays CEO’s FCA appeal has ended in failure. https://t.co/UTZcoDtKN0 ...

Starling and Revolut expand overseas, Starmer climbs down on welfare cuts and can the Wimbledon Effect continue? -- get briefed ahead of your morning calls with The London Rush https://t.co/8buH0dsHrZ ...

ECB May Need to Hold Rates Amid ‘Two-Sided’ Risks, Knot Tells FT https://t.co/4iBw88CLm3 ...